To determine the requirement of cysteine in preterm infants with different gestational ages and postnatal age.
Completed
- Registration Number
- NL-OMON21228
- Lead Sponsor
- Sophia Children’s Hospital Fund, the NetherlandsP.O. Box 20603000 CB Rotterdam
- Brief Summary
1. Am J Clin Nutr. 2007 Oct;86(4):1120-5.<br> 2. Pediatrics. 2008 Mar;121(3):e561-7. Epub 2008 Feb 18. <br>
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1. Infants born with a gestational age of 26-29 weeks will be studied at a post-conceptional age of 30-32 weeks and at a post-conceptional age of 35-37 weeks.
2. Infants born at a gestational age of 32-34 weeks will also be studied at a post-conceptional age of 35-37 weeks.
Exclusion Criteria
1. Congenital metabolic disease;
2. Congenital anomalies;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Fractional oxidation of 13C-phenylalanine;<br /><br>2. Whole body flux of 13C-phenylalanine.
- Secondary Outcome Measures
Name Time Method